Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Zhongyin Pharmaceutical is a comprehensive pharmaceutical company based in Beijing, China, that specializes in the research, development, and large-scale manufacturing of chemical drugs and traditional Chinese medicines (TCM). The company maintains a diverse product portfolio that addresses major therapeutic areas such as cardiovascular health, endocrinology, and infectious diseases. Key commercial products include widely used medications like Amlodipine Besylate for hypertension and Metformin Hydrochloride for diabetes management. Beijing Zhongyin Pharmaceutical operates modern manufacturing facilities that are fully compliant with national Good Manufacturing Practice (GMP) standards. By integrating modern pharmacological research with traditional herbal expertise, the company aims to provide high-quality and affordable healthcare solutions to the domestic Chinese market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Zhongyin Pharmaceutical.